Skip to main content
Livermore
Livermore
ZHEN

Gradient Capital Advisors, LLC

SEC CIK
0001727917
Latest filing
Jul 13, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Gradient Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
384
Value
$239.4K
% of portfolio
0.1%
Quarters held
16
Since Q3 2022
Holdings of REGN by Gradient Capital Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026384$239.4K0.1%00.0%UnchangedHolders
Q1 2026384$296.7K0.1%00.0%UnchangedHolders
Q4 2025384$296.4K0.1%−1−0.3%ReducedHolders
Q3 2025385$216.5K0.1%+1+0.3%AddedHolders
Q2 2025384$201.6K0.1%00.0%UnchangedHolders
Q1 2025384$243.5K0.1%00.0%UnchangedHolders
Q4 2024384$273.5K0.1%00.0%UnchangedHolders
Q3 2024384$403.7K0.1%00.0%UnchangedHolders
Q2 2024384$403.6K0.1%00.0%UnchangedHolders
Q1 2024384$369.6K0.1%00.0%UnchangedHolders
Q4 2023384$337.3K0.1%00.0%UnchangedHolders
Q3 2023384$316.0K0.1%00.0%UnchangedHolders
Q2 2023384$275.9K0.1%00.0%UnchangedHolders
Q1 2023384$315.5K0.1%00.0%UnchangedHolders
Q4 2022384$277.1K0.1%00.0%UnchangedHolders
Q3 2022384$265.0K0.1%+384NewHolders